Caleb Richard Schatz McEntire, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukoencephalopathy, Progressive Multifocal | 2 | 2023 | 130 | 1.510 |
Why?
|
Lyme Neuroborreliosis | 1 | 2024 | 50 | 0.900 |
Why?
|
Cranial Nerve Diseases | 1 | 2024 | 112 | 0.890 |
Why?
|
Optic Neuritis | 1 | 2024 | 174 | 0.790 |
Why?
|
Headache Disorders | 1 | 2024 | 139 | 0.780 |
Why?
|
Leukoencephalopathies | 1 | 2024 | 248 | 0.760 |
Why?
|
JC Virus | 1 | 2021 | 86 | 0.730 |
Why?
|
Central Nervous System Infections | 1 | 2021 | 61 | 0.720 |
Why?
|
Facial Paralysis | 1 | 2024 | 345 | 0.690 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2021 | 140 | 0.680 |
Why?
|
Spinal Cord Diseases | 1 | 2021 | 288 | 0.620 |
Why?
|
Lyme Disease | 1 | 2024 | 630 | 0.600 |
Why?
|
Sarcoidosis | 1 | 2023 | 515 | 0.590 |
Why?
|
Central Nervous System Diseases | 1 | 2021 | 519 | 0.540 |
Why?
|
Fingers | 1 | 2016 | 504 | 0.430 |
Why?
|
Arm | 1 | 2016 | 584 | 0.420 |
Why?
|
Spinal Cord | 1 | 2021 | 1804 | 0.420 |
Why?
|
Communicable Diseases | 1 | 2021 | 871 | 0.420 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2024 | 2127 | 0.390 |
Why?
|
MPTP Poisoning | 3 | 2016 | 36 | 0.370 |
Why?
|
Psychomotor Performance | 1 | 2016 | 1872 | 0.300 |
Why?
|
Cranial Nerves | 1 | 2024 | 96 | 0.220 |
Why?
|
Limbic Encephalitis | 1 | 2023 | 36 | 0.220 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2023 | 71 | 0.210 |
Why?
|
Hashimoto Disease | 1 | 2023 | 98 | 0.210 |
Why?
|
Brain Ischemia | 1 | 2016 | 3128 | 0.200 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2021 | 68 | 0.190 |
Why?
|
Encephalitis | 1 | 2023 | 430 | 0.170 |
Why?
|
Infarction | 1 | 2021 | 248 | 0.170 |
Why?
|
Neuroma | 1 | 2020 | 116 | 0.160 |
Why?
|
Cognition | 1 | 2016 | 6862 | 0.160 |
Why?
|
Recovery of Function | 2 | 2016 | 2952 | 0.120 |
Why?
|
Emergencies | 1 | 2021 | 1176 | 0.120 |
Why?
|
HIV Infections | 1 | 2021 | 17006 | 0.120 |
Why?
|
DNA, Viral | 1 | 2021 | 2176 | 0.110 |
Why?
|
Stroke | 1 | 2016 | 9887 | 0.110 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 1 | 2013 | 66 | 0.110 |
Why?
|
Fetal Tissue Transplantation | 1 | 2013 | 137 | 0.110 |
Why?
|
Motor Skills | 1 | 2016 | 521 | 0.110 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2016 | 481 | 0.100 |
Why?
|
Mesencephalon | 1 | 2013 | 329 | 0.100 |
Why?
|
Acute Disease | 1 | 2021 | 7217 | 0.090 |
Why?
|
Dopamine | 2 | 2016 | 1578 | 0.090 |
Why?
|
Neural Stem Cells | 1 | 2016 | 875 | 0.080 |
Why?
|
Dependovirus | 1 | 2013 | 698 | 0.080 |
Why?
|
Young Adult | 2 | 2024 | 57732 | 0.070 |
Why?
|
Humans | 11 | 2024 | 752810 | 0.070 |
Why?
|
Male | 7 | 2024 | 355160 | 0.070 |
Why?
|
Brain | 4 | 2023 | 26820 | 0.060 |
Why?
|
Adolescent | 2 | 2024 | 86822 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2016 | 17960 | 0.060 |
Why?
|
Adult | 3 | 2024 | 217168 | 0.060 |
Why?
|
Tremor | 1 | 2023 | 186 | 0.050 |
Why?
|
Aged | 3 | 2024 | 166705 | 0.050 |
Why?
|
Leukoencephalitis, Acute Hemorrhagic | 1 | 2021 | 18 | 0.050 |
Why?
|
Female | 5 | 2024 | 386339 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5722 | 0.050 |
Why?
|
Plasmapheresis | 1 | 2021 | 204 | 0.050 |
Why?
|
Middle Aged | 2 | 2024 | 217250 | 0.040 |
Why?
|
Parkinson Disease | 1 | 2013 | 2834 | 0.040 |
Why?
|
Corpus Striatum | 2 | 2016 | 1221 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 36038 | 0.040 |
Why?
|
Behavior, Animal | 2 | 2016 | 1853 | 0.040 |
Why?
|
Parthenogenesis | 1 | 2016 | 31 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2021 | 657 | 0.040 |
Why?
|
Treatment Outcome | 1 | 2023 | 64288 | 0.030 |
Why?
|
Child | 1 | 2024 | 78996 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2076 | 0.030 |
Why?
|
Neurons | 1 | 2014 | 9352 | 0.030 |
Why?
|
Mental Disorders | 1 | 2014 | 6694 | 0.030 |
Why?
|
Infectious Anemia Virus, Equine | 1 | 2013 | 4 | 0.030 |
Why?
|
Brain Tissue Transplantation | 1 | 2013 | 81 | 0.030 |
Why?
|
Organic Chemicals | 1 | 2014 | 210 | 0.030 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2014 | 371 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1052 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1573 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2021 | 79160 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2146 | 0.020 |
Why?
|
Animals | 4 | 2016 | 166825 | 0.020 |
Why?
|
Cell Count | 1 | 2014 | 1834 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1599 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2683 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2014 | 2118 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3699 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1712 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4006 | 0.020 |
Why?
|
Linear Models | 1 | 2014 | 5858 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2013 | 3354 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15695 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11004 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6746 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8549 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18918 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11424 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11882 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 39885 | 0.010 |
Why?
|